Mofebutazone
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-butyl-1-phenylpyrazolidine-3,5-dione | |
| Identifiers | |
| ATC code | M01AA02 (WHO) M02AA02 (WHO) |
| PubChem | CID 16639 |
| ChemSpider |
15776 |
| UNII |
SPW36WUI5Z |
| KEGG |
D07262 |
| ChEBI |
CHEBI:76252 |
| Chemical data | |
| Formula | C13H16N2O2 |
| Molar mass | 232.27834 g/mol |
| |
| |
| | |
Mofebutazone (or monophenylbutazone) is a drug used for joint and muscular pain. It is a 3,5-pyrazolinedione derivative.
The drug binds to plasma albumin and competes with drugs such as coumarin anticoagulants, indomethacin and glucocorticoids.
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
